Methods	Randomised, double-blind, placebo-controlled, cross-over, not enriched. No imputation method mentioned Titration to limit of tolerability or maximum of 3600 mg over 4 weeks, then stable dose for remainder of 8-week period; 2-week washout then cross-over
Participants	Complete traumatic SCI at lumbar or thoracic level. N = 20, mean age 36 years, 35% women. Pain duration before treatment ≥ 6 months, PI at randomisation > 4/10, initial average daily pain 9/10
Interventions	Gabapentin 3600 mg daily (max) Placebo Mean max tolerated dose of gabapentin 2850 ± 751 mg No concurrent analgesics allowed
Outcomes	Pain reduction (mean data only) Adverse events Withdrawals
Notes	Oxford Quality Score: R = 1, DB = 2, W = 1, Total = 4
Risk of bias
Item	Authors’ judgement	Description
Allocation concealment?	Unclear	Not reported
Blinding? All outcomes	Yes	“identically appearing capsules”
Incomplete outcome data addressed? Efficacy	Unclear	Imputation not mentioned
Size Efficacy	No	20 randomised
Study duration Efficacy	Yes	8-week period
Outcomes reported	No	No dichotomous data